Objective High white matter hyperintensity (WMH) burden is commonly found on brain MRI among patients with atrial fibrillation (AF). However, whether the link between AF and WMH extends beyond a common vascular risk factor profile is uncertain. We sought to determine whether AF relates to a distinct WMH lesion pattern which may suggest specific underlying pathophysiological relationships. Methods We retrospectively analysed a cohort of consecutive patients presenting with embolic stroke at an academic hospital and tertiary referral centre between March 2010 and March 2014. In total, 234 patients (53% female, 74% anterior circulation infarction) fulfilled the inclusion criteria and were included in the analyses. WMH lesion distribution was classified according to previously defined categories. Multivariable logistic regression analysis was performed to determine variables associated with AF within 90 days of index hospital discharge. results Among included patients, 114 had AF (49%). After adjustment for the CHA 2 DS 2 -VASc score (congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, prior stroke/TIA (doubled), vascular disease, age 65-74 years, sex category (female)) score, WMH lesion burden as assessed on the Fazekas scale, embolic stroke pattern, infarct distribution and pertinent interaction terms, AF was significantly associated with presence of anterior subcortical WMH patches (OR 3.647, 95% CI 1.681 to 7.911, p=0.001). conclusions AF is associated with specific WMH lesion pattern among patients with embolic stroke aetiology. This suggests that the link between AF and brain injury extends beyond thromboembolic complications to include a cardiovasculopathy that affects the brain and can be detected and characterised by WMH.
IntrOductIOn
White matter hyperintensity (WMH) lesions are commonly found on MRI, and several studies found a high WMH lesion burden among patients with atrial fibrillation (AF). [1] [2] [3] It has been hypothesised that AF mediates WMH pathogenesis through chronic silent microembolisation. 4 Indeed, conversion of acute small infarcts into WMH has been documented, which supports the notion that cerebral microembolism contributes to the development of WMH. 5 6 Though AF has been related to the severity of WMH, results regarding an independent association of AF with WMH have been conflicting. [7] [8] [9] [10] [11] [12] A better understanding of the link between AF and WMH has the potential to provide insight into underlying pathophysiological mechanisms as well as open novel avenues to patient selection for costly diagnostic examinations or treatment decisions. For example, despite overall declining rates, cryptogenic stroke remains an important public health and clinical problem, accounting for 20-30% of all ischaemic strokes. 13 14 The majority of cryptogenic ischaemic strokes are thought to be embolic in origin and AF is increasingly recognised as a cause. 13 14 Diagnosing paroxysmal AF in this patient population remains a clinical challenge and only 5% of patients are diagnosed with AF at the time of their stroke. 15 New guidelines suggest that more intensive monitoring leads to higher rates of AF detection, but cost and logistical challenges exist to long-term screening for AF among all patients with cryptogenic stroke. 16 Defining novel imaging markers associated with AF might help better identify patients at risk for AF to better target these patients for further workup, including more intense AF screening. 13 17 Although MRI is frequently used to assess infarct topography to provide clues regarding stroke aetiology, no infarct pattern has been identified that is pathognomonic for AF-related cerebral embolism. 13 Likewise, no characteristic WMH pattern has been identified that links AF with WMH.
Using a previously established WMH lesion pattern system, 18 we sought to determine whether WMH patterns differ between patients presenting with AF versus non-AF embolic ischaemic stroke aetiology, independent of the overall WMH lesion burden or vascular risk factor profile. Given the known association between AF and chronic brain microembolism, 5 6 we hypothesised that AF preferentially relates to a WMH pattern characterised by multiple subcortical spots. 18 
MethOds study cohort
We retrospectively analysed 234 patients with acute ischaemic stroke shown on brain MRI and included in the University of Massachusetts Memorial Medical Center Stroke registry between March 2010 and March 2014 followed for 90 days. [19] [20] [21] In accordance with our primary hypothesis, we
ReSeARCH pApeR
Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke included patients in whom the stroke aetiology was defined as (i) definite or possible cardioembolic, (ii) non-cardioembolic but a cardioembolic cause could not be excluded (competing aetiology) and (iii) patients with an embolic stroke of undetermined source. Given our stated goal to determine WMH patterns in patients with embolic stroke aetiology, we excluded patients with large artery atherosclerosis and cerebral small vessel disease-related stroke mechanism. We further restricted analyses to patients with brain MRI to reliably determine WMH and to exclude stroke mimics. Our investigation was approved by our Institutional Review Board (#H00006964) and Health Insurance Portability and Accountability Act waiver of informed consent granted. We adhere to the STrengthening the Reporting of OBservational studies in Epidemiology guidelines (www. strobe-statement. org).
clinical characteristics, stroke aetiology and stroke severity
Patient demographics, laboratory data, comorbidities and pre-admission medications were abstracted from the medical record by trained physician abstractors. Stroke aetiology (using the Causative Classification System for ischaemic stroke (CCS) 22 ) based on diagnostic evaluation were collected on all patients (http:// ccs. mgh. harvard. edu). In brief, the CCS is a free web-based, semiautomated, evidence-based classification system that assigns the most likely causative mechanism in a rule-based manner to five major categories (based on the Trial of ORG-10172 in Acute Stroke Treatment classification) of patients with additional subdivision according to the weight of evidence (evident, probable and possible) of an assignment. 22 Members of the stroke team certified in National Institutes of Health Stroke Scale (NIHSS) scoring graded the severity of stroke at presentation.
risk factor definitions
We determined the presence of hypertension (use of antihypertensive medications or systolic blood pressure of ≥140 mm Hg or diastolic blood pressure of ≥90 mm Hg on two separate occasions), hypercholesterolaemia (use of lipid-lowering agents or fasting blood total cholesterol level of ≥200 mg/dL or low-density lipoprotein cholesterol (LDLc) of ≥130 mg/dL) and diabetes mellitus (defined according to the National Diabetes Data Group and WHO 23 ). Cardiac studies were obtained at the treating physicians' discretion and included transthoracic echocardiography or transoesophageal echocardiography, electrocardiography and 30-day event monitoring. All patients were submitted to continuous 24 hour inpatient cardiac telemetry per institutional protocol. For all participants, we calculated the congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, prior stroke/TIA (doubled), vascular disease, age 65-74 years, sex category (female) (CHA 2 DS 2 -VASc) score (range 0-9) based on data available in the medical record. The qualifying stroke was counted towards the CHA 2 DS 2 -VASc-score; thus, the minimal possible score in our cohort was 2.
Atrial fibrillation
AF was defined according to the American Heart Association guidelines criteria. 24 Patients with AF in the setting of rheumatic mitral valve disease, a prosthetic heart valve or mitral valve repair (valvular AF) were included in this study. 24 25 For the purposes of our analyses, we considered AF present if AF was documented in the admission history, if AF was present on a per-protocol, admission 12-lead ECG or if they had a history of oral anticoagulation for AF. In addition, abstractors reviewed all clinical notes, 30-day non-invasive monitor reports, implantable device reports (including pacemaker and implantable loop recorders), as well as all 12-lead ECGs obtained for any reason for newly diagnosed AF within 90 days of index hospital discharge.
Image analysis

WMH
was defined on fluid-attenuated inversion recovery (FLAIR) MRI according to the STandards for ReportIng Vascular changes on nEuroimaging 26 criteria and graded according to the Fazekas scale as previously described in detail. 19 27 The total Fazekas score was calculated by adding the periventricular and deep white matter lesion scores. 19 WMH lesion patterns were defined by readers (YM, JH) who were blinded to clinical data and follow-up scans. Based on the grading scheme recently reported by Charidimou and colleagues, we defined five WMH lesion patterns on FLAIR MRI (figure 1). 18 These patterns included (i) multiple subcortical spots, (ii) large (extending >5 mm in the deep white matter) anterior subcortical patches (ASPs), (iii) large posterior subcortical patches and (iv) severe confluent subcortical WMH lesions. 
cerebrovascular disease
In addition, we denoted (v) an isolated periventricular patternthis pattern was defined by the presence of WMH in contact with the ventricles in the absence of additional subcortical WMH lesions. Patients without WMH were included in this group. The previously reported peri-basal ganglia pattern (WMH following the peripheral outline of the basal ganglia) was present in two patients. 18 These patients were coded according to their overlapping pattern: one with a severe confluent pattern and one with multiple subcortical spots. We tested the interobserver reliability of the readers' assessment on 50 randomly chosen scans by Krippendorff 's α test with 10 000 bootstrap samples. 28 This analysis demonstrated an excellent interobserver agreement for WMH lesion pattern analysis (α=0.95).
statistics
Unless otherwise stated, continuous variables are reported as mean±SD or median (25th-75th quartile). Categorical variables are reported as proportions. Between-group comparisons for continuous and ordinal variables were made with MannWhitney U test and Kruskal-Wallis one-way analysis of variance by ranks as appropriate and correlations between the CHA 2 DS 2 -VASc score and Fazekas score were examined with Spearman's rank correlation test. Categorical variables were compared using the χ 2 test. Bonferroni method was used to correct for multiple comparisons.
To determine whether WMH lesion patterns (periventricular patches and ASP) were associated with AF (dependent variable), we constructed a multivariable logistic regression model adjusted for the CHA 2 DS 2 -VASc score and WMH lesion burden as assessed by the Fazekas score as well as the two-way and three-way interactions between WMH lesion pattern, Fazekas score and CHA 2 DS 2 -VASc score. In addition, we adjusted for the presence of an embolic stroke pattern as well as presence of an anterior versus posterior circulation infarct distribution. Patients with both anterior and posterior circulation infarctions were categorised according to the vascular territory with the main infarct burden. To avoid model overfitting, a backward elimination method (likelihood ratio) was used for all models. Collinearity diagnostics were performed (and its presence rejected) for all multivariable regression models. The Hosmer-Lemeshow goodness-of-fit statistic was used to assess model fit.
Two-sided significance tests were used throughout and unless stated otherwise a two-sided p<0.05 was considered statistically significant. All statistical analyses were performed using IBM SPSS Statistics V. 22 .
results
Of 632 patients with ischaemic stroke, 234 patients fulfilled the study criteria and were included. Of included patients, 114 had AF (49%) and 120 (51%) were not diagnosed with AF (figure 2). A total of 156 (67%) patients had isolated anterior circulation strokes, 54 (23%) had isolated posterior circulation strokes and 24 (10%) subjects had ischaemic strokes both in the anterior and posterior circulation. Among patients with combined anterior and posterior circulation strokes, the main infarct burden was in the anterior circulation in 18 and in the posterior circulation in 6 patients. Overall, 110 subjects had a definite cardioembolic stroke aetiology (47%), 58 had a probable/possible cardioembolic stroke aetiology (25%), 33 had a competing aetiology (14%) and 33 had an embolic stroke of undetermined source (14%), respectively (figure 2).
Baseline characteristics of included versus excluded patients with available MRI are summarised in table 1. Overall, included patients were older, had a greater CHA 2 DS 2 -VASc-score, were more frequently female and had a higher admission NIHSS (p<0.001 each, table 1). In addition, included patients more frequently had anterior circulation infarcts (p=0.038), had a worse preadmission modified Rankin scale (mRS) (p=0.001), more frequently had hypertension (p=0.017) and were treated with antihypertensives (p=0.003) as well as less frequently had diabetes mellitus (p=0.014) and had a lower glycated haemoglobin A1c (HbA1c) (p=0.036). Further, included patients had a lower LDLc (p=0.032). There was no difference in the overall WMH lesion burden between included and excluded patients (p=0.190) and cardiac workup was similar except for more frequent evaluation by transoesophageal echocardiography of included patients (p=0.018).
Baseline characteristics of included patients stratified by the AF status are summarised in table 2. Patients with AF were on average older (p<0.001), more likely to be female (p=0.004), more likely to be treated with an anticoagulant (p<0.001) and antihypertensive medication (p=0.006) on admission compared with patients not diagnosed with AF. In addition, patients with AF had higher admission NIHSS (p<0.001), baseline CHA 2 DS 2 -VASc score (p<0.001) and higher Fazekas score (p=0.001) as well as more frequently had ASP and less frequently had periventricular WMH patches compared with patients without AF (p<0.001, each; figure 3). Consistent with our focus on patients with embolic stroke aetiology, there was no difference in the prevalence of embolic-appearing infarcts on MRI (p=0.104). Last, patients with AF had a higher pre-stroke mRS (p=0.021). The prevalence of rheumatic mitral valve disease, a prosthetic heart valve or mitral valve repair was equally distributed between patients with AF (n=9; valvular AF) versus without AF (n=11; p=0.817). Although the overall WMH lesion pattern did not differ between these 20 patients (p=0.322, χ 2 -test), all patients cerebrovascular disease (n=2) with an anterior subcortical WMH lesion pattern were in the valvular AF group. Since AF and WMH share vascular risk factors included in the CHA 2 DS 2 -VASc score, we assessed associations between CHA 2 DS 2 -VASc score and WMH lesion burden, as well as between CHA 2 DS 2 -VASc score and WMH lesion patterns. As expected, we found a significant correlation between CHA 2 DS 2 -VASc score and Fazekas score (r=0.470, p<0.001; figure 4) . Further, the WMH lesion pattern distribution was significantly different between CHA 2 DS 2 -VASc score categories (p<0.001 for trend). On post hoc analysis, subjects with a CHA 2 DS 2 -VASc score of 8 and 9 more frequently had ASP and a severe confluent pattern and less frequently had subcortical and large posterior patches compared with patients with lower CHA 2 DS 2 -VASc scores (p<0.05, data not shown).
On multivariable logistic regression, presence of ASP (p=0.001) and higher CHA 2 DS 2 -VASc score (p=0.002) was significantly associated with AF (table 3) . The WMH severity, as assessed by the Fazekas score, presence of an embolic infarct pattern and infarct location were not retained in the final model. Importantly, there was no interaction between ASP and the CHA 2 DS 2 -VASc as well as the Fazekas score, showing that the association of ASP with AF was not dependent on the vascular risk factor and WMH lesion burden, respectively (table 3) .
Further, statistically significant associations between ASP and AF remained in sensitivity analyses that excluded patients with competing stroke aetiologies (n=201; OR 4.516, 95% CI 1.932 to 10.556, p=0.001). Additionally, adjusting for treatment with antihypertensives, antiglycaemics, antithrombotics and baseline serum creatinine did not meaningfully change the results (data not shown). When we entered the individual vascular risk factors that are included in the CHA 2 DS 2 -VASc score instead of the summary score into the final step of the main multivariable model, presence of ASP (p=0.005), older age (p<0.001), presence of multiple infarcts (p=0.024) and presence of vascular disease (p=0.020) were independently associated with AF (data not shown). Lastly, because the original definition of the Fazekas scale distinguished between periventricular and deep WMH lesions, we conducted additional analyses to examine periventricular versus deep WMH lesion burden as both ordinal (each ranging from 0 to 3) or dichotomised (WMH present or absent) variables in lieu of the total Fazekas score. In univariable analyses, both periventricular (p=0.005) and deep (p=0.001) Fazekas scores were greater among patients with AF (table 2) . Conversely, presence of periventricular (p=0.002) but not deep (p=0.876) WMH was associated with a non-AF stroke aetiology (table 2) . After adjustment, the ASP lesion pattern remained independently associated with AF (p<0.01 in all models), whereas 
dIscussIOn
In this moderately sized cohort of patients with embolic stroke mechanism, MRI neuroimaging and systematic assessment for AF, we observed that AF is associated with a distinct WMH lesion pattern. In contrast to our original hypothesis, we noted a statistically significant association between AF and anterior subcortical WMH patches. Relations between AF and this WMH pattern persisted even after rigorous adjustment for other potential covariates or confounders, including factors relating to an embolic stroke aetiology and overall WMH lesion burden. Given the typical locations of embolic infarcts in patients with AF, 29 and the postulated link of AF to WMH through chronic silent microembolisation, 4 5 we originally hypothesised that AF relates to a WMH pattern characterised by multiple subcortical spots. However, our contrasting finding of an independent association of ASP with AF challenges the view that chronic embolism accounts for AF-related WMH because preferential Data are n (%) or median (25th-75th quartiles). CHA 2 DS 2 -VASc, congestive heart failure, hypertension, age≥75 years (doubled), diabetes mellitus, previous stroke/TIA (doubled), vascular disease, age 65-74 years, sex category (female); HbA1c, glycated haemoglobin A1c; LDLc, low-density lipoprotein cholesterol; mRS, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; WMH, white matter hyperintensity.
embolism into the anterior subcortical white matter is unlikely. Furthermore, our result of an absent association between WMH burden and AF after adjustment for vascular risk factors is in line with the majority of previous studies.
7-12
Our results may provide the impetus for further study to determine the specific pathomechanistical links between AF and WMH. Possibly, endothelial dysfunction or impaired cardiac output with chronic cerebral hypoperfusion might be contributing mechanisms. 21 An alternative explanation may be an as of yet to be determined shared genomic link between AF and WMH. The possibility for such a link is supported by recent exciting observations: genome-wide association studies have associated the paired like homeodomain 2 (Pitx2) gene with AF as well as stroke related to AF 30 31 and subsequent investigations have linked Pitx2 to cerebral small vessel disease-related pathology providing a genetic rationale how AF may be uniquely linked to WMH. 32 The identification of a unique pathophysiological substrate for AF associated WMH may ultimately help us better understand clinical phenomena observed among patients with AF.
For example, it is well established that patients with AF are at elevated risk for poor poststroke functional outcomes, cognitive impairment and dementia, independent of incident strokes. 21 33-36 The hypothesis that the association between small vessel disease-related sequelae such as cognitive impairment is likely independent of established links between cardiovascular risk factors and overt ischaemic stroke is further supported by observations that did not find a clear association between intracranial large artery and cerebral small vessel disease as well as absent association of intracranial large artery disease with cognitive impairment after adjustment for small vessel disease markers such as WMH. 37 Although the observational nature of our study precludes causal inference, our results do support the hypothesis that complex pathomechanisms that extend beyond clinically manifest thromboembolic 
Figure 4
Correlation between the white matter hyperintensity lesion burden as assessed by the Fazekas score and the congestive heart failure, hypertension, age≥75 years (doubled), diabetes mellitus, previous stroke/TIA (doubled), vascular disease, age 65-74 years, sex category (female) (CHA 2 DS 2 -VASc) scores in the studied population (r=0.470, p<0.001). The degree of correlation was similar for patients with atrial fibrillation (AF; r=0.426; p<0.001) and without AF (r=0.456; p<0.001).
Bubble size corresponds to the number of patients in each category (inset indicates the number of patients by bubble diameter; grey-scale in inset is exclusively used to differentiate circle size and is not proportional to the number of patients.). cerebrovascular disease events link AF to cognitive impairment and dementia because anterior WMH topography has been associated with frontal cortical thinning and cognitive dysfunction. 38 Pending confirmation in future prospective studies, our findings may be of additional clinical relevance by using WMH pattern analysis as a readily assessable imaging biomarker that can help better target patients at high risk for AF for more intensive and cost-effective monitoring programmes. 39 Nevertheless, our results should be considered cautiously and hypothesis generating only. Although we noted a high specificity (0.91) for the association of ASP with AF, the sensitivity was low (0.30). Therefore, WMH pattern analysis should presently not be used as a clinical screening tool for AF.
Strengths of our study relate to inclusion of consecutive patients with available MRI, and evaluation of WMH patterns by two blinded examiners, restriction of analyses to patients with suspected embolic infarct aetiology, the rigorous adjustment for important factors associated with WMH and protocol-driven, previously validated assessments for AF. Limitations relate to its retrospective and observational nature as well as moderate sample size. Thus, although we demonstrate a strong and novel association between AF and anterior subcortical WMH pattern, our research design does not allow us to infer causality. Not all patients without AF underwent long-term cardiac monitoring and analyses were restricted to the first 90 days after hospital discharge. Yet, while this may have caused us to underestimate the incidence of AF this would be expected to bias our results towards the null hypothesis. In addition, owing to the retrospective study nature we were unable to collect detailed information regarding the duration and type of AF. This, in conjunction with WMH quantification, may provide additional insight into the association between AF and WMH that will require elaboration in future, prospective studies.
cOnclusIOn
Our study shows that AF is associated with anterior WMH lesion pattern on brain MRI. The clinical significance of this observation remains to be clarified, but our findings suggest that the established links between stroke and AF extend beyond thromboembolism and perhaps reflect an underlying cardiovasculopathy that can be characterised by WMH. Further investigation into the pathophysiological mechanisms underlying associations between WMH pattern and AF may provide novel avenues to enhance AF detection and stroke treatment.
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